Foundation Medicine
Transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease.
Launch date
Employees
Market cap
-
Enterprise valuation
€49—74m (Dealroom.co estimates Jan 2013.)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$33.5m | Series A | ||
N/A | $42.5m | Series B | |
$13.5m | Series B | ||
N/A | N/A | IPO | |
N/A | N/A | Acquisition | |
Total Funding | €87.7m |
Related Content
Recent News about Foundation Medicine
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.